LabCompass

Xiaoyan Lin

Medicine · Indiana University

OpenAlex ORCID
Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchPain Mechanisms and TreatmentsGastric Cancer Management and OutcomesFerroptosis and cancer prognosis

Publications

55

Citations

831

Est. group size

—

Recurring co-author estimate

Active years

30

Publishing since 1996

Research summary
AI-generated

Xiaoyan Lin conducts cancer-focused biomedical research, studying the molecular and genetic drivers of tumors (including breast, gastric, and lung cancers) and evaluating new drug therapies through both laboratory experiments and clinical trials. The work spans identifying genes and proteins that influence tumor growth and prognosis, as well as testing targeted drugs and immune-based treatments in patients. Some studies also examine cardiovascular disease mechanisms.

Cancer molecular biology and tumor biomarkersClinical trials of targeted and immunotherapy drugsBreast and gastric cancer researchCardiovascular disease mechanismsPan-cancer genetic analysis

Publication activity grew through the early 2020s, peaking around 2021-2023, with a steady output of roughly five papers per year in recent years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 5.4/year recently
172018: 1 publication182019: 5 publications192020: 2 publications202021: 6 publications212022: 10 publications10222023: 8 publications232024: 4 publications242025: 5 publications2526
Recent publications
Publishes in
  • Research Square×5
  • Journal of Clinical Oncology×2
  • Genes & Diseases×2
  • PubMed×2
  • Molecular Immunology×1

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile